Ignite Creation Date:
2025-12-25 @ 1:14 AM
Ignite Modification Date:
2026-01-09 @ 12:41 PM
Study NCT ID:
NCT00795093
Status:
COMPLETED
Last Update Posted:
2010-05-11
First Post:
2008-11-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Partial Response to Proton Pump Inhibitors (PPI) Treatment: The Cost to Society and the Burden to the Patient - a Study in the US
Sponsor:
AstraZeneca
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
D9120N00005
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Debra Silberg, MD PhD, Medical Science Director, Clinical Research
Old Organization:
AstraZeneca R&D
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |